3 results match your criteria: "Paoli-Calmettes Institute iAix Marseille University[Affiliation]"
Eur J Cancer Prev
June 2015
aDepartment of Oncology and Hematology, Paul-Brousse University Hospital, Inserm U1004, Villejuif bCoordination Center for Cancer Screening, Bretonneau 2 University Hospital, Tours cKantar Health, Montrouge dDepartment of Medical Oncology, Jean Minjoz University Hospital, Inserm U645, Besançon eLéon Bérard Cancer Centre, Lyon fPorte de Saint-Cloud Clinic, Boulogne-Billancourt gRoche, Boulogne Billancourt hDepartment of Cancer Control, Paoli-Calmettes Institute iAix Marseille University, UMR_S912, IRD jINSERM, UMR912 (SESSTIM), Marseille, France.
One of the current goals of the French national cancer plan is to reduce healthcare inequalities. This study investigated the potential links between vulnerable social status, exposure to lung cancer risk factors and access to healthcare to highlight ways to improve lung cancer control in this population. The nationwide observational study EDIFICE 3 was carried out through phone interviews of a representative sample of 1603 individuals (age 40-75 years).
View Article and Find Full Text PDFEur J Cancer Prev
June 2015
aDepartment of Medical Oncology, Jean Minjoz University Hospital, Inserm U645, Besançon bCoordination Center for Cancer Screening, Bretonneau University Hospital, Tours cKantar Health, Montrouge dDepartment of Oncology and Hematology, Paul-Brousse University Hospital, Inserm U1004, Villejuif eLéon Bérard Cancer Centre, Lyon fPorte de Saint-Cloud Clinic, Boulogne-Billancourt gRoche, Boulogne-Billancourt hCancer Control Department, Paoli-Calmettes Institute iAix Marseille University, UMR_S912, IRD jINSERM, UMR912 (SESSTIM), Marseille, France.
The Cochrane analysis exploring the risk/benefit ratio of breast cancer screening resulted in a controversy worldwide spread by the mass media. Our survey sought to assess the impact of this controversy in terms of breast cancer screening awareness and attendance. A nationwide observational study, recorded in the EDIFICE iterative surveys, with a representative sample of 451 women aged 40-75 years, living in France, was carried out in the 3 months after the start of the controversy in January 2013.
View Article and Find Full Text PDFEur J Cancer Prev
June 2015
aCoordination Center for Cancer Screening, Bretonneau University Hospital, Tours bDepartment of Oncology and Hematology, Paul-Brousse University Hospital, Inserm U1004, Villejuif cKantar Health, Montrouge dPorte de Saint-Cloud Clinic, Boulogne-Billancourt eRoche, Boulogne-Billancourt fLéon Bérard Cancer Centre, Lyon gDepartment of Medical Oncology, Jean Minjoz University Hospital, Besançon hCancer Control Department, Paoli-Calmettes Institute iAix Marseille University, UMR_S912, IRD jINSERM, UMR912 (SESSTIM), Marseille, France.
The EDIFICE programme began in 2005 and set out to provide a clearer insight over time into the participation of the French population in cancer screening. EDIFICE 3 was conducted in 2011 by phone interviews among a representative sample of 1603 individuals aged between 40 and 75 years using the quota method. The analysis focused on the target populations (50-74 years) of the national screening programmes for breast and colorectal cancer.
View Article and Find Full Text PDF